Patient Handling Articles & Analysis

As new coronavirus variants continue to mutate and spread, the growth in demand for infection prevention solutions using UV-C light is projected to reach $18.94 billion by 2030, witnessing an annual growth rate of 59.7% from 2021 to 2030. Further fueling the demand is the rise in hospital acquired infections (HAIs) that globally cause more fatalities due to the increase in antibiotic resistance ...

By Blue Ocean Robotics

Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT) announced that the National Cancer Institute (NCI) has resumed enrolling patients into their pharmacologic study of the ability of Lixte’s lead compound, LB-100, to enter the brain and penetrate recurrent, malignant brain tumors, in patients where surgical removal of their cancer is indicated. After enrolling two patients in the study, ...

By LIXTE Biotechnology Holdings, Inc.

Today, Blue Ocean Robotics the manufacturer of UVD Robots for autonomous UV-C disinfection announced that it was selected by ISS World Services, one of the world’s leading global workplace experience and facility management companies, to provide autonomous robots for disinfection as part of ISS’ global offering. The agreement allows ISS to offer hospital-grade disinfection to its ...

By Blue Ocean Robotics

In the last couple of years, the corona virus has caused a huge impact all across Europe. UVD Robots and Blue Ocean Robotics - the manufacturer of the autonomous disinfecting robot equipped with UV-C light - was selected by the European Commission, as a supplier for its autonomous disinfection robots to European Union hospitals in the fight against SARS-CoV-2 known as Coronavirus. Each year ...

By Blue Ocean Robotics

Infection control procedures including work practices, protocols and controls, environmental hygiene, air filtration and appropriate use of Personal Protective Equipment (PPE) are all necessary to prevent infections from spreading during healthcare service delivery. But in the case of the recent Coronavirus (COVID-19) outbreak early detection and isolation of potentially infectious patients is ...

By Genano Industrial Air Purification Solutions - Genano Ltd.

Roughly 8% of U.S. adults suffer from persistent or chronic back pain. That’s around 65 million people who are prevented from engaging in daily activities. Many are forced to miss days of work due to injury. With rising healthcare costs, many back pain sufferers think that they are left without a real solution, until they try epidural injections. An epidural injection is the infusion of ...

By Milestone Scientific, Inc.